chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 2 months after receiving his vaccines, patient developed chest pains and presented to the hospital. He was noted to have elevated troponins (6) and ST segment elevations on EKG. He was admitted from 8/12-8/17 where he was on telemetry and seen by Infectious Disease, Cardiology. His ECHO was normal. He received scheduled ibuprofen and his troponin downtrended upon discharge.
After 7 days of vaccination (shingrix) , pt stated the tingling pain woke her up, she experienced swelling arms and pinch pain, dry mouth, diziness and shaking. She went to the emergency room because could not reach her Dr. Dr checked her blood pressure ok and gave her ibuprofen.
Around  7pm started feeling arm pain and then the next day arm was swollen and sore today arm is still swollen and now its swollen in my armpit
Female was vaccinated with Moderna Covid-19 and was 17 years of age at the time.  She and her mother were not aware at the time of the first in the series that the EUA was approved for 18 year-olds and older.  She and her mother agreed to receive the second dose of the Moderna Covid-19 on 5/5/21- as recommended by the CDC.  Both child and mother denies any side-effects from the first vaccine given on 4/7/21.
congestion in the throat and upper lungs; congestion in the throat and upper lungs; This is a spontaneous report from a contactable other healthcare professional (patient). A 61-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EK5730), intramuscular on the left arm on 21Dec2020 09:30 at a single dose for COVID-19 immunization. The patient's medical history included herpes 2. The patient was not pregnant. The patient had no known allergies to medications, food, or other products. There were no concomitant medications. The patient was not diagnosed with COVID-19 prior to vaccination and had not been tested for COVID-19 since the vaccination. On 26Dec2020 09:00, the patient experienced congestion in the throat and upper lungs. Oxygen level was 98 and temperature was 97.7. She had a good diet, no dairy, and no Christmas junk food, so for the patient, it was inexplicable. She was also consistent at mask wearing and all the precautions. No treatment was received for the adverse events. Outcome of the events was not recovered. The events were reported as non-serious.; Sender's Comments: Considering the temporal gap between the vaccination and the event onset, the Company considers the event pulmonary congestion is unlikely related to vaccination with BNT162B2. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Pt briefly fainted after received 3 vaccines. Loss of consciousness for 5-10 seconds immediately after 3rd vaccine administered.
Hospitalization: 9/18/2022 - 9/21/2022 Presentation to the ED: VAGINAL BLEEDING.  COVID-19 + date: 9/19/22. Treatment: PATIENT WAS ASYMPTOMATIC. NO TREATMENT GIVEN.  Discharge to: Home or Self Care.
Quite a bit of pain and swelling in the left arm around the injection site, chills,headache,abdominal cramping all presented within 12 hours.
On 09/11/2022 I received my Covid-19 vaccine. On the morning of 02/09/2023 I was experiencing a sore throat, runny nose and cough. After reaching out to my doctor I was prescribed Paxlovid. Symptoms lasted approx. 5 days and symptoms went away however the next day I retested and was positive with symptoms returning. I reached out to my doctor again and was prescribed Flonase. Symptoms lasted another week.
Swelling at the injection site; Soreness at the injection site; Redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE PAIN (Soreness at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE PAIN (Soreness at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site). At the time of the report, VACCINATION SITE SWELLING (Swelling at the injection site), VACCINATION SITE PAIN (Soreness at the injection site) and VACCINATION SITE ERYTHEMA (Redness at the injection site) outcome was unknown.
BAD REACTION; BRAIN FOG; BAD HEADACHE; BAD DRY MOUTH; SWEATING AND FREEZING ALL NIGHT LONG; HORRIBLE CHILLS; This spontaneous report received from a patient concerned a 62 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, and expiry: 25/MAY/2021) dose was not reported, administered on 24-MAR-2021 for prophylactic vaccination. Concomitant medications included atorvastatin. On 24-MAR-2021, the subject experienced sweating and freezing all night long. On 24-MAR-2021, the subject experienced horrible chills. On 25-MAR-2021, the subject experienced bad dry mouth. On 25-MAR-2021, the subject experienced bad headache. On 26-MAR-2021, the subject experienced brain fog. On an unspecified date, the subject experienced bad reaction. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sweating and freezing all night long, and horrible chills on 25-MAR-2021, and brain fog, had not recovered from bad dry mouth and bad headache, and the outcome of bad reaction was not reported. This report was non-serious.
Left arm pain; generalized malaise; i was wiped out and wanted to sleep all day; This is a spontaneous report from a contactable Nurse. A 52-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EJ1685), via an unspecified route of administration on 22Dec2020 07:15 at a single dose (dose number 1, left arm) for COVID-19 immunization. Medical history included HIV+ and COVID-19 from an unspecified date. Concomitant medication included bupropion hydrochloride (WELLBUTRIN), trazodone, oxazepam (SERAX), valaciclovir hydrochloride (VALTREX), and ibuprofen from an unspecified date for an unspecified indication. The patient has allergies to Tegretol and AZT. The patient was diagnosed with COVID-19 prior to vaccination. The patient had no other vaccine in four weeks. The patient experienced left arm pain, generalized malaise (he was wiped out and wanted to sleep all day) on 22Dec2020 09:00. Treatment was not given. Event outcome was recovering. Since the vaccination, the patient has not been tested for COVID-19. The events were assessed as non-serious.
Received PNEUMOVAX left deltoid 8/3/10. That eve developed fever like sx, left arm pain, swelling, redness. Advised ice elevation.
After my vaccine, my baby had growth restriction, found out about this at 32 weeks.  I developed gestational hypertension which turned into preeclampsia. My baby was born at 37 weeks.   My baby is still small but is growing well.  At the time of  my second vaccine: I was 25 weeks
pt recv vax 11JUL96 & 21JUL96 pt devel low grade fever, redness of one of eyes & flat, dark red 1 cm spots;f/u indicated that pt was not a regular pt but granddaughter of a regular pt;
Within 10-15 seconds starting turning red in face and head - hot - feel bad all down her spine. Settled in lower back. 12:08 (8 minutes) later, feeling better. Had tightness in chest 2 5 minutes onto reaction. Had called MD - when chest tight - hung up and called 911. 12:12pm much better drank water
Patient got a routine booster shot of TD vaccine and experienced a large upper arm reaction, size of fist.  It was swollen, red and hot to touch.  Patient experienced pain up to her neck. Follow up on 08/31/2004:  Patient was treated with Benadryl and over the counter hydrocortisone cream.  Patient recovered.
Firm, red, warm lump at site on injection. General malaise and sore throat.
Patient reports itching and hives about 2 weeks after receiving first dose of Pfizer COVID vaccine. Patient is on Dupixent therapy.
Fingers on right hand numb, numbness moved to palm and arm and continued for 90 minutes. Numbness then moved to right side of face and throat. Both arms felt heavy. Numbness moved to shoulder, neck, ear, face, then headache on back left side. Through 10/11/21 both arms still feel heavy and neck is sore and stiff.
headache; tiredness/ bouts of extreme fatigue; Sore arm; This is a spontaneous report from contactable consumer (patient). A 53-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left arm on 04Mar2021 08:30 (Batch/Lot number was not reported) at the age of 53 years old as second dose, single dose for COVID-19 immunization. The patient's medical history was not reported. The patient's concomitant medication wasreported as none. Prior vaccinations within four weeks was reported as none. The patient previously received first dose of BNT162B2, anatomical site of injection: left arm on 09Feb2021 at 8:45 AM for COVID-19 immunization. The patient experienced tiredness on 04Mar2021 at 12:00, headache on 04Mar2021 at 17:00 and sore arm on 04Mar2021 (also reported as "07Apr2021", pending clarification) at 9:00. Patient also stated that "I received the second dose of vaccine on 3Apr. Since then I have had bouts of extreme fatigue. Is this a long term side effect?" (pending clarification)  The events did not required treatment (initiation of new medication/other treatment/ procedure). The outcome of the event "tiredness/bouts of extreme fatigue" was recovered on 25Mar2021, for headache was recovered on 05Mar2021 and for "Sore arm" was recovered on 06Mar2021.  No follow up attempts are possible. No further information expected.
Information has been received from a pharmacy student concerning a 57 year old female who in October 2010, was vaccinated with a dose of PNEUMOVAX 23 (dose and route not reported, reported lot# was invalid) and shortly after developed shortness of breath. The patient saw physician. At the time of reporting, the outcome was unknown. Additional information has been requested.
first dose on 3-NOV-2020, not yet received second; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received first dose on 3rd November 2020).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 22-Jul-2022 Reporter's comment: The patient had not yet received her second dose. The reporter did not consent to follow up. Additional Supportive Information: Till the time of reporting the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.
First couple of day's experiences nausea and a slight headache. Since 4/6/21 serious debilitating headaches 8 of the last 9 days. Migraine meds, sinuses meds, tylenol,  sinus washes, and ice packs all have provided little relief.
Twelve hours post vax, the pt experienced a total body rash with itching. Treatment included Benadryl and prednisone. The reporting physician considered the events incapacitating. 15-day follow up received on 9/5/00 states the pt's past hx.
Immunizations administered on 11/7/02. Presented in clinic 11/12/02 with rash confined to upper and lateral thighs (bilateral). Rough, raised papular lesions. Patient also had band aids on for several days - adhesive.
STERILE WATER FOR INJECTION MIXED IN AS DILUENT.  No-Known-Adverse-Reaction (NKAR) AT TIME OF REPORT FROM PATIENT FROM EVENT.
HPI: Patient is a 45 year old man with a recent COVID 19 illness (August) requiring ICU stay and immunosuppressive therapy was admitted on 11/4 for altered mental status. He felt almost fully recovered, was doing work around the house, cooking meals and improving however last week he had a week of feeling more sleepy, eating less and his wife said sleeping 16 hours at times. He developed acute nausea with diaphoresis and chills and word finding issues the morning of his admit. He presented with a WBC and CSF revealed a pleocytosis. Workup was unremarkable-both cultures and images and symptoms resolved quickly. He was discharged but had a seizure on the way home and returned for further therapy. Today he states that he has a bad headache but is otherwise feeling improved. His meningitis therapy was reinitiated on admit.  Impression: Patient is a 45 year old man with post covid syndrome including tachycardia, weakness and now with seizures likely as a sequelae of the disease. His initial presentation included an extensive workup with negative imaging, labs with a leukocytosis that resolved quickly and CSF studies that had a lympo/mono predominance, all consistent with seizure activity. Patient said that he had his flu shot Thursday and he wondered if it could have contributed by causing more inflammation. It is possible the shot caused an increase in his overall inflammatory state. Vaccines have been described as causing aseptic meningitis although these are rare events. We will be sure to report this occurrence to the VAERS database.    Assessment/Plan: 1. CSF pleocytosis, aseptic meningitis- likely seizure related. Ok to d/c antivirals, antimicrobials. Vaccine induced vs part of the sequelae of long covid. Difficult to discern. Will report to VAERS 2. Seizure d/o- per neurology 3. Leukocytosis- resolved 4. Post covid, long covid diagnosis- continue to follow with appropriate consultants. I recommended vaccination for covid once symptoms have resolved and closer to 6-8 months following his initial infection.
Extreme fatigue and exhaustion. Vomiting (unable to keep any food down). Headache. Symptoms lasted around 12 hours (8am to evening). Fatigue remained the following day. First pregnancy, EDD 10/31/2022. Pain at injection site in right arm lasted for several weeks.
Headache; tiredness; body aches; arm soreness at shot site; arm soreness at shot site and through arm and shoulder; arm soreness at shot site and through arm and shoulder; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 09Apr2021 at 12:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient had no allergies to medications, food, or other products. Concomitant medications included paracetamol (TYLENOL), escitalopram oxalate (LEXAPRO), calcium carbonate, magnesium carbonate (TUMS) and mefenamic acid (ADVIL), all taken for unspecified indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 18Mar2021 at 11:45 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 05:00, the patient experienced headache, tiredness, body aches, arm soreness at shot site and through arm and shoulder. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events headache, tiredness, body aches, arm soreness at shot site and through arm and shoulder were resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Subsequent to receiving three doses of Engerix B, the pt was found to be a non-responder. On 04/21/2000, the pt received the fourth dose of Engerix B. She was again found to be a non-responder. As of 08/09/2000, the outcome of the event is unknown.
Patient was brought in by ambulance from pharmacy due to throat swelling and difficulty breathing after receiving the COVID vaccine. Pt was given 50mg IM Benadryl by pharmacy staff.
No adverse event; Monovalent ages 6-11 vaccine administered instead of receiving Moderna Covid-19 Vaccine, Bivalent; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Monovalent ages 6-11 vaccine administered instead of receiving Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) in a 30-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR6965B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 14-Oct-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Oct-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Monovalent ages 6-11 vaccine administered instead of receiving Moderna Covid-19 Vaccine, Bivalent). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Monovalent ages 6-11 vaccine administered instead of receiving Moderna Covid-19 Vaccine, Bivalent) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Monovalent ages 6-11 vaccine administered instead of receiving Moderna Covid-19 Vaccine, Bivalent).    Concomitant product use was not provided by the reporter.  Patients got Moderna Covid-19 vaccine with Blue Capped Purple-Bordered (Ages 6-11 MONOVALENT) instead of receiving Moderna Covid-19 Vaccine Bivalent.  Treatment information was not provided.
CLIENT HAS NO PRIMARY SERIES COVID VACCINES AS STATED IN VACCINE QUESTIONAIRE. CLIENT WAS GIVEN A BIVALENT BOOSTER AS A PFIZER FIRST DOSE.
7-22-15 redness, swelling and warmth at the injection site. Patient given ZYRTEC and ibuprofen and will return in 24 hours. 7-23-15 symptoms improved, patient discharged.
Pt reported light headache and tightness in throat area. Vitals 1304 142/90, 85, 16, 96.6F -- > 123/67, 80, 16 98.0F, Sat 100% Pt given water.  PT drank a total of 700mL. 13:20 Pt reported that she was feeling better w/ no more tightness in the throat area.  Pt stood up and walked stably, balanced well. Pt stable and released from the vaccination site @13:22
3:30PM Vomiting, 15 to 20 episodes with diarrhea X3. Went to ER, possible reaction, sent home. 13th still vomiting, no diarrhea, using Pedialyte. 14th had 2 episodes of each, on Pedialyte. 15th vomited once, 2 diarrhea stools in am only, none since noon, using Pedialyte. Temp remained normal. No abdominal pain on palpation throughout. No one else in family ill.
NONE: Vaccine Expired 10/25/2023, given 02/06/2023
I received the first dose of the Pfizer at the pharmacy on Wed 9/22 I had slight soreness but nothing concerning. On 9/23 I woke up with extreme pain in my left leg starting at my hip down to my foot, my right hip had a slight burn to it but nothing extreme, I left work at 8:30 am and drove to my Doctor as the pain was severe and I was leaning on walls to stay balanced. After leaving my doctors office I spent the next day and weekend laying in bed. To this point I still experience the pain and have a bad limp. I am currently taking celecoxib 200 mg
Mother noticed redness, swelling and itching this AM at injection site. Benadryl given per DR.
Patient called today and stated next day c/o itching, swelling to ZOSTAVAX site with H/A and nausea. Received rx 2/1/14 for cellulitis.
sore left arm; This is a spontaneous report from a contactable Nurse. 64-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EKS730), intramuscular (IM) on 18Dec2020 at single dose on left upper arm once for COVID-19 immunisation. There were no medical history and concomitant medications. The patient stated that she did not have anything with the first shot except a sore left arm on 18Dec2020. She stated that if she lays on left side it was sore. The event was considered as non-serious. The outcome of the event was not recovered.
hair loss and hair thinning shortly after receiving the vaccine; hair loss and hair thinning shortly after receiving the vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ALOPECIA (non-serious), ALOPECIA (non-serious), outcome "unknown" and all described as "hair loss and hair thinning shortly after receiving the vaccine".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200055983 same reporter/drug/event, different patient
On 5/22/2021, the patient, who was (and is) and inpatient at a healthcare facility, developed a fever to 101.4 F, had blood cultures drawn, and one bottle has grown Staphylococcus aureus (oxacillin-susceptible). No source for the bacteremia has been found.
Fine rash all over upper body; Started 8 hr after injection; Itching really bad; Treatment was Benadryl P.O.
Headache, Myalgia, Arthralgia,  arm pain, fatigue, nasal congestion Narrative: